{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:41:38Z","timestamp":1778222498745,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-024-01263-w","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T16:01:54Z","timestamp":1727798514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-9357","authenticated-orcid":false,"given":"Rosanna","family":"Tarricone","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-6919","authenticated-orcid":false,"given":"Francesco","family":"Petracca","sequence":"additional","affiliation":[]},{"given":"Hannah-Marie","family":"Weller","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"1263_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/14737167.2021.1891883","volume":"21","author":"R Tarricone","year":"2021","unstructured":"Tarricone, R., Petracca, F., Ciani, O. & Cucciniello, M. Distinguishing features in the assessment of mHealth apps. Expert Rev. Pharmacoecon. Outcomes Res. 21, 521\u2013526 (2021).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"1263_CR2","unstructured":"IMDRF. \u201cSoftware as a medical device\u201d: possible framework for risk categorization and corresponding considerations. https:\/\/www.imdrf.org\/sites\/default\/files\/docs\/imdrf\/final\/technical\/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf (2014)."},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41746-020-00371-7","volume":"3","author":"K Kadakia","year":"2020","unstructured":"Kadakia, K., Patel, B. & Shah, A. Advancing digital health: FDA innovation during COVID-19. Npj Digit. Med. 3, 161 (2020).","journal-title":"Npj Digit. Med."},{"key":"1263_CR4","unstructured":"Medical Device Coordination Group. MDCG 2019-11: guidance on qualification and classification of software in regulation (EU) 2017\/745 \u2013 MDR and regulation (EU) 2017\/746 \u2013 IVDR. https:\/\/health.ec.europa.eu\/system\/files\/2020-09\/md_mdcg_2019_11_guidance_qualification_classification_software_en_0.pdf (2019)."},{"key":"1263_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1197949","volume":"11","author":"F Mezei","year":"2023","unstructured":"Mezei, F. et al. International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary. Front. Public Health 11, 1197949 (2023).","journal-title":"Front. Public Health"},{"key":"1263_CR6","doi-asserted-by":"publisher","first-page":"e49003","DOI":"10.2196\/49003","volume":"11","author":"R Van Kessel","year":"2023","unstructured":"Van Kessel, R. et al. Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping. JMIR MHealth UHealth 11, e49003 (2023).","journal-title":"JMIR MHealth UHealth"},{"key":"1263_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/picr.PICR_89_19","volume":"11","author":"R Khirasaria","year":"2020","unstructured":"Khirasaria, R., Singh, V. & Batta, A. Exploring digital therapeutics: the next paradigm of modern health-care industry. Perspect. Clin. Res. 11, 54 (2020).","journal-title":"Perspect. Clin. Res."},{"key":"1263_CR8","unstructured":"European Union. Regulation (EU) 2021\/2282 of the European Parliament and of the Council of 15 December 2021 on Health Technology Assessment and Amending Directive 2011\/24\/EU (Text with EEA Relevance). https:\/\/eur-lex.europa.eu\/eli\/reg\/2021\/2282\/oj\/eng (2021)."},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10198-022-01458-6","volume":"23","author":"M Drummond","year":"2022","unstructured":"Drummond, M., Tarricone, R. & Torbica, A. European union regulation of health technology assessment: what is required for it to succeed? Eur. J. Health Econ. 23, 913\u2013915 (2022).","journal-title":"Eur. J. Health Econ."},{"key":"1263_CR10","unstructured":"European Commission, Directorate-General for Health and Food Safety. Flash report - member state coordination group on HTA (HTACG) (16 November 2023). https:\/\/health.ec.europa.eu\/system\/files\/2023-11\/hta_20231117_flash_en.pdf (2023)."},{"key":"1263_CR11","unstructured":"European Taskforce for Harmonised Evaluations of Digital Medical Devices (DMDs). European taskforce for harmonised evaluations of digital medical devices (DMDs). https:\/\/eithealth.eu\/european-taskforce-for-harmonised-evaluations-of-digital-medical-devices-dmds\/ (2023)."},{"key":"1263_CR12","unstructured":"European Commission. Funding & tender opportunities. Development and harmonisation of methodologies for assessing digital health technologies in Europe HORIZON-HLTH-2023-IND-06-07. https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/horizon-hlth-2023-ind-06-07;callCode=null;freeTextSearchKeyword=HORIZON-HLTH-2023;matchWholeText=true;typeCodes=1,0;statusCodes=31094501,31094502,31094503;programmePeriod=2021%20-%202027;programCcm2Id=43108390;programDivisionCode=43108557;focusAreaCode=null;destinationGroup=null;missionGroup=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=topicSearchTablePageState (2023)."},{"key":"1263_CR13","unstructured":"Gesetz F\u00fcr Eine Bessere Versorgung Durch Digitalisierung Und Innovation (Digitale-Versorgung-Gesetz\u2014DVG) [Digital Healthcare Act] of 9 December, BGBl I at 2562 (Germany, 2019). (2019)."},{"key":"1263_CR14","unstructured":"Verordnung \u00dcber Das Verfahren Und Die Anforderungen Der Pr\u00fcfung Der Erstattungsf\u00e4higkeit Digitaler Gesundheitsanwendungen in Der Gesetzlichen Krankenversicherung (Digitale Gesundheitsanwendungen-Verordnung\u2014DiGAV) [Digital Health Applications-Ordinance] of 8 April, BGBl I at 768 (Germany, 2020). (2020)."},{"key":"1263_CR15","unstructured":"Bundesministerium f\u00fcr Gesundheit. Gesetz Zur Beschleunigung Der Digitalisierung Des Gesundheitswesens (Digital-Gesetz). https:\/\/www.bundesgesundheitsministerium.de\/service\/gesetze-und-verordnungen\/detail\/digital-gesetz.html (2023)."},{"key":"1263_CR16","unstructured":"Bundesministeriums f\u00fcr Gesundheit. Verordnung Zur Erstattungsf\u00e4higkeit Digitaler Pflegeanwendungen \u2013 VDiPA (Ordinance on the eligibility for reimbursement of digital nursing applications - DiPAV). https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/3_Downloads\/Gesetze_und_Verordnungen\/GuV\/V\/vdipa_refe_bf.pdf (2022)."},{"key":"1263_CR17","unstructured":"San Miguel, L. et al. Evaluation of digital medical technologies. (Belgian Health Care Knowledge Centre (KCE), BE, 2023)."},{"key":"1263_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.therap.2019.12.009","volume":"75","author":"Y Le Douarin","year":"2020","unstructured":"Le Douarin, Y. et al. Telemonitoring and experimentation in telemedicine for the improvement of healthcare pathways (ETAPES program). Sustainability beyond 2021: What type of organisational model and funding should be used? Therapies 75, 43\u201356 (2020).","journal-title":"Therapies"},{"key":"1263_CR19","unstructured":"R\u00e9publique Fran\u00e7aise. D\u00e9cret N\u00b0 2023-232 Du 30 Mars 2023 Relatif \u00e0 La Prise En Charge Anticip\u00e9e Des Dispositifs M\u00e9dicaux Num\u00e9riques \u00e0 Vis\u00e9e Th\u00e9rapeutique et Des Activit\u00e9s de T\u00e9l\u00e9surveillance M\u00e9dicale Par l\u2019assurance Maladie Au Titre de l\u2019article L. 162-1-23 Du Code de La S\u00e9curit\u00e9 Sociale. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000047377863\/2024-01-29\/ (2023)."},{"key":"1263_CR20","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte. Das Fast-Track-Verfahren f Digitale Gesundheitsanwendungen (DiGA) Nach \u00a7 139e SGB V - Version 3.5. https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Medizinprodukte\/diga_leitfaden.pdf?__blob=publicationFile"},{"key":"1263_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09287-w","volume":"23","author":"M M\u00e4der","year":"2023","unstructured":"M\u00e4der, M. et al. Evidence requirements of permanently listed digital health applications (DiGA) and their implementation in the German DiGA directory: an analysis. BMC Health Serv. Res. 23, 369 (2023).","journal-title":"BMC Health Serv. Res."},{"key":"1263_CR22","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Real-world studies for the assessment of medicinal products and medical devices. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-06\/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf (2021)."},{"key":"1263_CR23","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Organisational impact map for health technology assessment. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-04\/organisational_impact_map_for_health_technology_assessment.pdf (2020)."},{"key":"1263_CR24","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Methodology for the clinical development of medical devices. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-09\/guide_methodology_for_the_clinical_development_of_md.pdf (2021)."},{"key":"1263_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12962-022-00359-y","volume":"20","author":"D Gensorowsky","year":"2022","unstructured":"Gensorowsky, D., Witte, J., Batram, M. & Greiner, W. Market access and value-based pricing of digital health applications in Germany. Cost. Eff. Resour. Alloc. 20, 25 (2022).","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"1263_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41746-024-01137-1","volume":"7","author":"L Schmidt","year":"2024","unstructured":"Schmidt, L., Pawlitzki, M., Renard, B. Y., Meuth, S. G. & Masanneck, L. The three-year evolution of Germany\u2019s Digital Therapeutics reimbursement program and its path forward. Npj Digit. Med. 7, 139 (2024).","journal-title":"Npj Digit. Med."},{"key":"1263_CR27","unstructured":"GKV-Spitzenverband. Rahmenvereinbarung Nach \u00a7 134 Abs. 4 Und 5 SGB V. https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/telematik\/digitales\/DiGA_Rahmenvereinbarung_nach_134_Abs_4_und_5_SGB_V_Stand_16.12.2021.pdf (2021)."},{"key":"1263_CR28","unstructured":"R\u00e9publique Fran\u00e7aise. Arr\u00eat\u00e9 Du 22 Avril 2024 Fixant Les Valeurs Pr\u00e9vues Au II de l\u2019article R. 162-117 Du Code de La S\u00e9curit\u00e9 Sociale de La Compensation Financi\u00e8re Due Au Titre de La Prise En Charge Anticip\u00e9e Par l\u2019assurance Maladie d\u2019un Dispositif M\u00e9dical Num\u00e9rique \u00e0 Vis\u00e9e Th\u00e9rapeutique. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000049467872 (2024)."},{"key":"1263_CR29","unstructured":"R\u00e9publique Fran\u00e7aise. Arr\u00eat\u00e9 Du 25 Octobre 2023 Fixant Les Valeurs de La Compensation Financi\u00e8re de l\u2019activit\u00e9 de T\u00e9l\u00e9surveillance M\u00e9dicale Dans Le Cadre d\u2019une Prise En Charge Anticip\u00e9e Num\u00e9rique Par l\u2019assurance Maladie Pr\u00e9vus Aux II et III de l\u2019article R. 162-117 Du Code de La S\u00e9curit\u00e9 Sociale. https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000048276415 (2023)."},{"key":"1263_CR30","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1017\/S0266462322000502","volume":"38","author":"J Haverinen","year":"2022","unstructured":"Haverinen, J., Turpeinen, M., Falkenbach, P. & Reponen, J. Implementation of a new Digi-HTA process for digital health technologies in Finland. Int. J. Technol. Assess. Health Care 38, e68 (2022).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"1263_CR31","unstructured":"TIC Salut Social. Apps certified by the TIC salut social foundation. https:\/\/ticsalutsocial.cat\/en\/que-fem\/actiusdigitals\/assets\/."},{"key":"1263_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-021-01748-1","volume":"45","author":"A Gessa","year":"2021","unstructured":"Gessa, A., Sancha, P. & Jim\u00e9nez, A. Quality assessment of health-apps using a public agency quality and safety seal. The appsaludable case. J. Med. Syst. 45, 73 (2021).","journal-title":"J. Med. Syst."},{"key":"1263_CR33","unstructured":"NICE (National Institute for Health and Care Excellence). Evidence Standards Framework for Digital Health Technologies. https:\/\/www.nice.org.uk\/corporate\/ecd7\/resources\/evidence-standards-framework-for-digital-health-technologies-pdf-1124017457605 (2022)."},{"key":"1263_CR34","doi-asserted-by":"publisher","first-page":"e39905","DOI":"10.2196\/39905","volume":"11","author":"J Segur-Ferrer","year":"2022","unstructured":"Segur-Ferrer, J., Molt\u00f3-Puigmart\u00ed, C., Pastells-Peir\u00f3, R. & Vivanco-Hidalgo, R. M. Methodological frameworks and dimensions to be taken into consideration in digital health technology assessment: protocol for a scoping review. JMIR Res. Protoc. 11, e39905 (2022).","journal-title":"JMIR Res. Protoc."},{"key":"1263_CR35","unstructured":"Segur-Ferrer, J., Molt\u00f3-Puigmart\u00ed, C., Pastells-Peir\u00f3, R., Estrada Sabadell, M. D. & Vivanco-Hidalgo, R. M. Marco de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias: Adaptaci\u00f3n Para La Evaluaci\u00f3n de Tecnolog\u00edas de Salud Digital. https:\/\/aquas.gencat.cat\/web\/.content\/minisite\/aquas\/publicacions\/2023\/marco-evaluacion-ts-salud-digital-redets-aquas2023.pdf (2023)."},{"key":"1263_CR36","unstructured":"EIT Health. Digital medical devices: paths to European harmonisation. https:\/\/eithealth.eu\/wp-content\/uploads\/2023\/02\/EIT_Health_Digital-Medical-Devices_Paths-to-European-Harmonisation.pdf (2023)."},{"key":"1263_CR37","unstructured":"International Organization for Standardization. ISO\/TS 82304-2:2021 health software. www.iso.org\/standard\/78182.html (2021)."},{"key":"1263_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41746-022-00573-1","volume":"5","author":"A Ess\u00e9n","year":"2022","unstructured":"Ess\u00e9n, A. et al. Health app policy: international comparison of nine countries\u2019 approaches. Npj Digit. Med. 5, 31 (2022).","journal-title":"Npj Digit. Med."},{"key":"1263_CR39","unstructured":"EIT Health. Towards harmonised EU landscape for digital health: summary of the roundtable discussions in selected EIT health InnoStars countries. https:\/\/eithealth.eu\/wp-content\/uploads\/2023\/02\/EIT_Health_DiGA_report_Jan2023.pdf (2023)."},{"key":"1263_CR40","unstructured":"Tervisekassa. Roadmap for digital solutions. https:\/\/tervisekassa.ee\/en\/partner\/roadmap-digital-solutions (2024)."},{"key":"1263_CR41","unstructured":"MySNS Comunidade. MySNS Sele\u00e7\u00e3o. https:\/\/mysns.min-saude.pt\/mysns-selecao\/."},{"key":"1263_CR42","unstructured":"Ministerstwo Zdrowia. Aplikacje Certyfikowane MZ. https:\/\/www.gov.pl\/web\/zdrowie\/aplikacje-certyfikowane-mz (2023)."},{"key":"1263_CR43","unstructured":"Nordic Digital Health Evaluation Criteria. https:\/\/norddec.org\/."},{"key":"1263_CR44","unstructured":"Danske Regioner. Dagsorden for M\u00f8de i Danske Regioners Bestyrelse Den 31. August 2023. https:\/\/www.regioner.dk\/media\/1bspjmwg\/aaben-dagsorden-med-bilag-3182023.pdf (2023)."},{"key":"1263_CR45","unstructured":"Indenrigs- og Sundhedsministeriet. Offentlig H\u00f8ring Af Bekendtg\u00f8relse Om Forretningsorden for N\u00e6vnet for Sundhedsapps. https:\/\/prodstoragehoeringspo.blob.core.windows.net\/1e369999-1b60-47c7-b27f-f0e61e8da2c0\/H%C3%B8ringsbrev.pdf (2024)."},{"key":"1263_CR46","doi-asserted-by":"crossref","unstructured":"Goetz, G., Jeindl, R., Panteli, D., Busse, R. & Wild, C. Digital health applications (DiHA): approaches to develop a re-imbursement process for the statutory health insurance in Austria. Health Policy Technol. 100780 (2023).","DOI":"10.1016\/j.hlpt.2023.100780"},{"key":"1263_CR47","unstructured":"Bundesministerium f\u00fcr Soziales, Gesundheit, Pflege und Konsumentenschutz. eHealth-Strategie \u00d6sterreich https:\/\/www.sozialministerium.at\/dam\/jcr:a23e90b2-48cf-4b72-aff4-c9d116b1f4ff\/eHealth-Strategie_%C3%96sterreich.pdf (2024)."},{"key":"1263_CR48","unstructured":"Camera dei deputati. Proposta Di Legge. Disposizioni in Materia Di Terapie Digitali. https:\/\/documenti.camera.it\/leg19\/pdl\/pdf\/leg.19.pdl.camera.1208.19PDL0040170.pdf (2023)."},{"key":"1263_CR49","unstructured":"Le gouvernement luxembourgeois. Accord de Coalition 2023\u20132028. https:\/\/gouvernement.lu\/fr\/publications\/accord-coalition\/accord-de-coalition-2023-2028\/accord-de-coalition-2023-2028.html (2023)."},{"key":"1263_CR50","doi-asserted-by":"publisher","first-page":"1203937","DOI":"10.3389\/fpubh.2023.1203937","volume":"11","author":"T Byrne","year":"2023","unstructured":"Byrne, T., Murray, N., McDonnell-Naughton, M. & Rowan, N. J. Perceived factors informing the pre-acceptability of digital health innovation by aging respiratory patients: a case study from the Republic of Ireland. Front. Public Health 11, 1203937 (2023).","journal-title":"Front. Public Health"},{"key":"1263_CR51","unstructured":"Spitzenverband Bund der Krankenkassen. Bericht Des GKV-Spitzenverbandes \u00dcber Die Inanspruchnahme Und Entwicklung Der Versorgung Mit Digitalen Gesundheitsanwendungen (DiGA-Bericht). https:\/\/www.gkv-spitzenverband.de\/media\/dokumente\/krankenversicherung_1\/telematik\/digitales\/2023_DiGA_Bericht_GKV-Spitzenverband.pdf (2023)."},{"key":"1263_CR52","unstructured":"Spitzenverband Digitale Gesundheitsversorgung. Marktentwicklung Digitaler Gesundheitsanwendungen. DiGA-Report. https:\/\/digitalversorgt.de\/wp-content\/uploads\/2024\/01\/DiGA-Report-2023-SVDGV.pdf (2023)."},{"key":"1263_CR53","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.lanepe.2024.100906","volume":"40","author":"J De Frutos Lucas","year":"2024","unstructured":"De Frutos Lucas, J. & Haugo, H. T. Moving forward with the European health data space: the need to restore trust in European health systems. Lancet Reg. Health Eur. 40, 100906 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"1263_CR54","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jamia\/ocac244","volume":"30","author":"N Alon","year":"2023","unstructured":"Alon, N. & Torous, J. Current challenges for evaluating mobile health applications. J. Am. Med. Inform. Assoc. 30, 617\u2013624 (2023).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"1263_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1017\/S026646232000015X","volume":"36","author":"C Vis","year":"2020","unstructured":"Vis, C., B\u00fchrmann, L., Riper, H. & Ossebaard, H. C. Health technology assessment frameworks for eHealth: a systematic review. Int. J. Technol. Assess. Health Care 36, 204\u2013216 (2020).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"1263_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1017\/S026646231800051X","volume":"34","author":"MR Moshi","year":"2018","unstructured":"Moshi, M. R., Tooher, R. & Merlin, T. Suitability of current evaluation frameworks for use in the health technology assessment of mobile medical applications: a systematic review. Int. J. Technol. Assess. Health Care 34, 464\u2013475 (2018).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"1263_CR57","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1017\/S0266462323002726","volume":"39","author":"JB Br\u00f6nneke","year":"2023","unstructured":"Br\u00f6nneke, J. B., Herr, A., Reif, S. & Stern, A. D. Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation. Int. J. Technol. Assess. Health Care 39, e72 (2023).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"1263_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hec.4505","volume":"31","author":"R Tarricone","year":"2022","unstructured":"Tarricone, R., Petracca, F., Cucciniello, M. & Ciani, O. Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps. Health Econ. 31, 73\u201397 (2022).","journal-title":"Health Econ."},{"key":"1263_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17434440.2023.2192868","volume":"20","author":"R Tarricone","year":"2023","unstructured":"Tarricone, R. et al. An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations. Expert Rev. Med. Devices 20, 259\u2013271 (2023).","journal-title":"Expert Rev. Med. Devices"},{"key":"1263_CR60","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJMp2305280","volume":"389","author":"PJ Neumann","year":"2023","unstructured":"Neumann, P. J. & Tunis, S. R. Turning CMS into a health technology assessment organization. N. Engl. J. Med. 389, 682\u2013684 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1263_CR61","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S2589-7500(21)00292-2","volume":"4","author":"AD Stern","year":"2022","unstructured":"Stern, A. D. et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit. Health 4, e200\u2013e206 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1263_CR62","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jval.2023.06.008","volume":"26","author":"M Haig","year":"2023","unstructured":"Haig, M., Main, C., Ch\u00e1vez, D. & Kanavos, P. A value framework to assess patient-facing digital health technologies that aim to improve chronic disease management: a delphi approach. Value Health 26, 1474\u20131484 (2023).","journal-title":"Value Health"},{"key":"1263_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08500-6","volume":"22","author":"H Lantzsch","year":"2022","unstructured":"Lantzsch, H., Eckhardt, H., Campione, A., Busse, R. & Henschke, C. Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results. BMC Health Serv. Res. 22, 1182 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"1263_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40273-022-01130-0","volume":"40","author":"M Gomes","year":"2022","unstructured":"Gomes, M., Murray, E. & Raftery, J. Economic evaluation of digital health interventions: methodological issues and recommendations for practice. PharmacoEconomics 40, 367\u2013378 (2022).","journal-title":"PharmacoEconomics"},{"key":"1263_CR65","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3390\/ijerph17062119","volume":"17","author":"K Kolasa","year":"2020","unstructured":"Kolasa, K. & Kozinski, G. How to value digital health interventions? A systematic literature review. Int. J. Environ. Res. Public. Health 17, 2119 (2020).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"1263_CR66","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41746-024-01209-2","volume":"7","author":"M Coder","year":"2024","unstructured":"Coder, M., McBride, L. & McClenahan, S. Core elements of national policy for digital health technology evidence and access. Npj Digit. Med. 7, 212 (2024).","journal-title":"Npj Digit. Med."}],"updated-by":[{"DOI":"10.1038\/s41746-024-01285-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000}}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01263-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T06:05:21Z","timestamp":1728972321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01263-w","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41746-024-01285-4","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41746-024-01285-4","URL":"https:\/\/doi.org\/10.1038\/s41746-024-01285-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests but the following competing non-financial interests: R.T. and F.P. are members of the European Taskforce for Harmonised Evaluations of Digital Medical Devices (DMDs); H.-M.W. is an employee of the European Commission.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}